Duangtum Natapol, Junking Mutita, Phadngam Suratchanee, Sawasdee Nunghathai, Castiglioni Andrea, Charngkaew Komgrid, Limjindaporn Thawornchai, Isidoro Ciro, Yenchitsomanus Pa-Thai
Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Graduate Program in Immunology, Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Biochem J. 2017 Jul 17;474(15):2573-2584. doi: 10.1042/BCJ20170088.
Mutations of the () gene encoding kidney anion (chloride/bicarbonate ion) exchanger 1 (kAE1) can cause genetic distal renal tubular acidosis (dRTA). Different mutations give rise to mutant kAE1 proteins with distinct defects in protein trafficking. The mutant kAE1 protein may be retained in endoplasmic reticulum (ER) or Golgi apparatus, or mis-targeted to the apical membrane, failing to display its function at the baso-lateral membrane. The ER-retained mutant kAE1 interacts with calnexin chaperone protein; disruption of this interaction permits the mutant kAE1 to reach the cell surface and display anion exchange activity. However, the mechanism of Golgi retention of mutant kAE1 G701D protein, which is otherwise functional, is still unclear. In the present study, we show that Golgi retention of kAE1 G701D is due to a stable interaction with the Golgi-resident protein, coat protein complex I (COPI), that plays a role in retrograde vesicular trafficking and Golgi-based quality control. The interaction and co-localization of kAE1 G701D with the γ-COPI subunit were demonstrated in human embryonic kidney (HEK-293T) cells by co-immunoprecipitation and immunofluorescence staining. Small interference RNA (siRNA) silencing of COPI expression in the transfected HEK-293T cells increased the cell surface expression of transgenic kAE1 G701D, as shown by immunofluorescence staining. Our data unveil the molecular mechanism of Golgi retention of kAE1 G701D and suggest that disruption of the COPI-kAE1 G701D interaction could be a therapeutic strategy to treat dRTA caused by this mutant.
编码肾脏阴离子(氯离子/碳酸氢根离子)交换蛋白1(kAE1)的()基因突变可导致遗传性远端肾小管酸中毒(dRTA)。不同的突变会产生在蛋白质运输方面存在明显缺陷的突变型kAE1蛋白。突变型kAE1蛋白可能会保留在内质网(ER)或高尔基体中,或者错误定位到顶端膜,无法在基底外侧膜发挥其功能。内质网保留的突变型kAE1与钙连蛋白伴侣蛋白相互作用;这种相互作用的破坏使突变型kAE1能够到达细胞表面并显示阴离子交换活性。然而,功能正常的突变型kAE1 G701D蛋白在高尔基体中保留的机制仍不清楚。在本研究中,我们表明kAE1 G701D在高尔基体中的保留是由于与高尔基体驻留蛋白衣被蛋白复合物I(COPI)的稳定相互作用,COPI在逆行囊泡运输和基于高尔基体的质量控制中发挥作用。通过共免疫沉淀和免疫荧光染色在人胚肾(HEK - 293T)细胞中证实了kAE1 G701D与γ-COPI亚基的相互作用和共定位。如免疫荧光染色所示,在转染的HEK - 293T细胞中,通过小干扰RNA(siRNA)沉默COPI表达可增加转基因kAE1 G701D在细胞表面的表达。我们的数据揭示了kAE1 G701D在高尔基体中保留的分子机制,并表明破坏COPI - kAE1 G701D相互作用可能是治疗由该突变引起的dRTA的一种治疗策略。